Cutting edge: Expression of functional CD137 receptor by dendritic cells

Journal of Immunology

Volumn 168, Issue 9, 2002, Pages 4262-4267

  Wilcox, Ryan A ^a   Chapoval, Andrei I ^a   Gorski, Kevin S ^a   Otsuji, Mizuto ^a   Shin, Tahiro ^a   Flies, Dallas B ^a   Tamada, Koji ^a   Mittler, Robert S ^a   Tsuchiya, Haruo ^a   Pardoll, Drew M ^a   Chen, Lieping ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD137 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 6; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CELL ISOLATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MODULATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0036569392     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.9.4262     Document Type: Article

References (43)

1. Immunobiology of dendritic cells
2. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
3. + T-helper and a T-killer cell
4. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
5. Activation of human dendritic cells through CD40 cross-linking
6. + T cells requires CD154 expression by Th cells in acute graft-versus-host disease
7. + cytotoxic T lymphocytes
8. The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity
9. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function
10. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation
11. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo
12. Biochemical and immunological characteristics of 4-IBB (CD137) receptor and ligand and potential applications in cancer therapy
13. + Tc1 and Tc2 cells
14. Costimulation of antigen-specific CD4 T cells by 4-IBB ligand
15. 4-IBB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy
16. Molecular cloning of a ligand for the inducible T cell gene 4-IBB: A member of an emerging family of cytokines with homology to tumor necrosis factor
17. Differential clonal expansion of CD4 and CD8 T cells in response to 4-IBB ligation: Contribution of 4-IBB during inflammatory responses
18. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
19. Monoclonal Abs against the 4-IBB T-cell activation molecule eradicate established tumors
20. Anti-4-IBB monoclonal Abs abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy
21. + T cell responses by administration of anti-CD137 ligand monoclonal Ab results in differential effect on development of murine acute and chronic graft-versus-host diseases
22. Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-IBB costimulation
23. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-IBB ligand: Synergy with the CD28 co-stimulatory pathway
24. Immunomodulatory gene therapy with interleukin 12 and 4-IBB ligand: Long-term remission of liver metastases in a mouse model
25. 4-IBBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine
26. Cutting edge: 4-IBB is a bona fide CD8 T cell survival signal
27. 4-IBB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses
28. Analysis of 4-IBB ligand (4-IBBL)-deficient mice and of mice lacking both 4-IBBL and CD28 reveals a role for 4-IBBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus
29. Analysis of expression and function of the costimulatory molecule 4-IBB in alloimmune responses
30. Ligation of 4-IBB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients
31. NK1.1 cells express 4-IBB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-IBB monoclonal Abs
32. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
33. Provision of antigen and CD137 signals to break immunological ignorance, promoting regression of poorly immunogenic tumors
34. Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors
35. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells
36. Dendritic cell subtypes in mouse lymphoid organs: Cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes
37. A mRNA variant encoding a soluble form of 4-IBB, a member of the murine NGF/TNF receptor family
38. + cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells
39. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-IBB-dependent immune response
40. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-IBB
41. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-IBB ligand
42. CD137 (ILA/4-IBB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes
43. Constitutive expression of functional 4-IBB (CD137) ligand on carcinoma cells